Business Services Industry

MGI PHARMA to Present at the BioCentury NewsMakers in the Biotech Industry Conference

Business Wire, Sept 2, 2005

MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Investment Conference on Friday, September 9, at 2:20 p.m. Eastern Time. Lonnie Moulder, president and chief executive officer of MGI PHARMA, will give the presentation, which will be webcast live over the Internet. The conference will be held at the Sheraton New York Hotel and Towers in New York City.

What: MGI PHARMA's presentation at the BioCentury NewsMakers in
          the Biotech Industry Conference

    When: Friday, September 9, 2005 at 2:20 p.m. Eastern Time

    How:  Live over the Internet - simply log on to www.mgipharma.com.
          In addition to the live webcast, the presentation will be
          archived on the Company's web site for one week.

About MGI PHARMA

MGI PHARMA, INC. is an oncology and acute care focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection, Kadian(R) (sustained release morphine sulfate) capsules, Salagen(R) Tablets (pilocarpine hydrochloride) and Hexalen(R) (altretamine) capsules in the United States. The company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.

COPYRIGHT 2005 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale